Form4insider filings, from the source

Insider holders · CIK 0001305253

Eiger BioPharmaceuticals, Inc. · EIGR

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
EcoR1 Capital, LLC10% Owner—2,843,1702,843,170Jun 30, 2015 · 1:22 pm EDTForm 3
Peter Kolchinsky10% Owner—2,415,4582,415,458Oct 25, 2018 · 5:20 pm EDTForm 3
RA CAPITAL MANAGEMENT, LLC10% Owner—2,415,4582,415,458Oct 25, 2018 · 5:20 pm EDTForm 3
RA Capital Healthcare Fund LP10% Owner—2,415,4582,415,458Oct 25, 2018 · 5:20 pm EDTForm 3
Nina S KjellsonDirector—1,599,5931,599,593Mar 31, 2016 · 8:19 pm EDTForm 3
Bruce A Cleveland10% Owner1,599,593—1,599,593Mar 31, 2016 · 7:48 pm EDTForm 3
W Stephen Holmes10% Owner1,599,593—1,599,593Mar 31, 2016 · 7:48 pm EDTForm 3
Philip T Gianos10% Owner1,599,593—1,599,593Mar 31, 2016 · 7:48 pm EDTForm 3
Keval Desai10% Owner1,362,327—1,362,327Oct 22, 2018 · 4:33 pm EDTForm 4
InterWest Management Partners X, LLC10% Owner1,362,327—1,362,327Oct 22, 2018 · 4:33 pm EDTForm 4
INTERWEST PARTNERS X LP10% Owner1,362,327—1,362,327Oct 22, 2018 · 4:33 pm EDTForm 4
Gilbert H Kliman10% Owner1,362,327—1,362,327Oct 22, 2018 · 4:33 pm EDTForm 4
Khaled Nasr10% Owner1,362,327—1,362,327Oct 22, 2018 · 4:33 pm EDTForm 4
Arnold L Oronsky10% Owner1,362,327—1,362,327Oct 22, 2018 · 4:33 pm EDTForm 4
Jeffrey S GlennDirector31,355151,064182,419Sep 5, 2017 · 6:20 pm EDTForm 4
David A CoryPresident and CEO58,67830,12388,801Feb 6, 2019 · 7:23 pm ESTForm 4
Eldon C. Mayer IIIDirector25,000—25,000Nov 30, 2018 · 2:26 pm ESTForm 4
Fredrik WiklundSee Remarks23,125—23,125Jan 5, 2015 · 8:36 pm ESTForm 4
Vivo Ventures VI, LLC10% Owner—12,99612,996Aug 22, 2016 · 1:43 pm EDTForm 4
Vivo Ventures Fund VI, L.P.10% Owner—12,99612,996Aug 22, 2016 · 1:43 pm EDTForm 4
VIVO VENTURES VI AFFIILATES FUND, L.P.10% Owner—12,99612,996Aug 22, 2016 · 1:43 pm EDTForm 4
Edgar EnglemanDirector—11,63211,632Mar 25, 2016 · 8:42 pm EDTForm 3
Thomas John DietzDirector10,000—10,000Dec 20, 2018 · 8:29 pm ESTForm 4
James P ShafferChief Business Officer5,620—5,620Aug 19, 2016 · 6:52 pm EDTForm 4
Krisztina M ZseboChief Executive Officer3,125—3,125Apr 7, 2015 · 4:38 pm EDTForm 4
Rebecque J LabaVP, Corporate Operations2,895—2,895Apr 3, 2015 · 4:12 pm EDTForm 4
James H WelchChief Financial Officer2,500—2,500Jun 22, 2016 · 2:55 pm EDTForm 4
Andrew C. JacksonSee Remarks1,587—1,587Mar 17, 2015 · 8:10 pm EDTForm 3
Ryan K TakeyaVP, Manufacturing1,432—1,432Apr 3, 2015 · 4:09 pm EDTForm 4
Jeffrey J RudyVP, Clinical Operations1,024—1,024Jan 12, 2015 · 6:28 pm ESTForm 4
Elizabeth E ReedVP, General Counsel169—169Jan 5, 2015 · 8:44 pm ESTForm 4
Joanne QuanChief Medical Officer0—0Apr 4, 2018 · 5:18 pm EDTForm 4
Peter HonigDirector0—0Mar 9, 2015 · 8:58 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.